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Tetanus immunity produced in man by injections of tetanus
toxoid is receiving an increasing amount of attention. That man
responds to two or three injections of such toxoid-preferably
alum-precipitated-with the production of antitoxin has been
established firmly by a number of investigators during the past
few years. Of the more recent work, that by Bergey and Etris,2
Bergey,' Jones and Moss,6 and Sneath7 may be mentioned. The
durationofthis immunity has been discussed by Sneath and Kerslake9
and by Bergey and Etris.3
However, the incidence of tetanus is so low that probably years
must elapse before the value of immunization can be determined
from statistics, and, in the meanwhile, even though man can be
immunized, we are confronted with questions which should be
answered before we put too much trust in the efficacy of the immu-
nity. This paper reports some results of attempts to answer two
of these questions, namely, the amount of antitoxin which we can
consider adequate to prevent tetanus following an infection, and
the speed of antitoxin response in a sensitized person who has
received an injection of toxoid.
The Amount of Antitoxin Adequate for Protection
Information on this phase of the subject can be obtained in
two ways. Statistics are available showing the efficacy of heter-
ologous antitoxin in prophylaxis in man, andwe can determine exper-
imentally in actively immunized animals the amount of circulating
antitoxin necessary to protect them from the results of tetanus
infection.
As for the first of these two methods of approach, experience
has shown that 1500 units administered subcutaneously is in most
cases sufficient to prevent tetanus, and Sneath8 has cited references
dealing with the persistence of such antitoxin in the blood stream.
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In brief, subcutaneous injection of this amount results in a serum
titer after three days of about 1/5 unit per cubic centimeter, and
in ten days of about 1/10 unit or less. Inasmuch as with slow heal-
ing wounds where infection persists for over a week it has been
found advisable to continue administration of antitoxin at weekly
intervals, it may be argued that 1/10 unit is in the neighborhood
of the minimal adequate protective titer. Much of this experi-
ence was secured with the severe wounds received under war con-
ditions. Since the titer required probably depends on the amount
of toxin produced, and as the latter may vary with the extent of
the necrosis, it seems logical to assume that in most infections inci-
dent to civil life, where the injury resulting in tetanus is usually
slight in nature, a lower titer may be sufficient. Bergey and Etris2 a
have suggested, drawing a not altogether convincing analogy with
diphtheria, that 1/100 unit may be satisfactory.
Experiments on tetanus infection in actively immunized animals
have given results which are recorded in the following tables (1
to 4). Such infections are, to be sure, relatively variable quantities.
The amount of toxin produced can, of course, never be determined
at all accurately, even if it were desirable. Francis4 has found that
scrapings from the sites of infections in guinea-pigs dying of tetanus
might contain from 100 to over 10,000 mouse minimal lethal doses
of toxin. It seems certain that the amount of toxin produced var-
ies greatly, but even so, infection would seem to offer more informa-
tion on immunity than the ability to resist injections of known
amounts oftoxin.
In these experiments calcium chloride was used as the tissue
debilitant, while a stock mixture of spores of Cl. tetani (A.T.C.C.
No. 4260) and Cl. tertium in the approximate ratio of four to
one constituted the infecting agent. The latter organism has no
deleterious action on tetanus toxin and was merely included as an
added hazard. Spore suspensions were kept in the ice-box and
were always heated for fifteen minutes at 800 C. immediately prior
to use in order to destroy any toxin that might be present. Injec-
tions of the spore-CaC12 mixture were made intramuscularly in
the thigh.
410TETANUS IMMUNIZATION 411
TABLE 1
GUINEA-PIGS
Immunization: subcutaneous injection of 0.25 cc. of alum-precipitated toxoid,
followed in two weeks by 0.25 cc. of plain toxoid. Ten days later blood was taken
from the heart, and each of the immune animals, together with the controls, received
immediately 100,000 spores and 10 mg. of CaCI2 contained in a 0.2 cc. volume.
]uTumber of Titer inunits
guinea-pigs per cc. ofserum Results
I < 1/5 None of the immunes had showed
Immunized 24 1/5 to 1 any signs of tetanus during a three-
2 > I month period.*
Controls 28 26 died in less than 46 hours with
tetanus. 1 paralyzed on the eighth
day, but lived. I showed nio
symptoms.
*Some functional impairment of the injected legs was noticeable for several
days. This wds attributed to the marked swelling resulting from the injection, and
not to tetanus.
TABLE 2
GUINEA-PIGS
Immunization: subcutaneous injection of 0.15 cc. of plain toxoid followed in four
weeks by 0.2 cc. of the same material. Eight days later blood was taken from the
heart, and each of the immune animals, together with the controls, received imme-
diately 25,000 spores and 10 mg. of CaCl2 in a 0.2 cc. volume.
Guinea-pig Titer in units
No. per cc. ofserum Results
I < 1/50 Tetanus. Killed on 6th day.
2 1/50 No symptoms.*
3 1/50 Local tetanus. Survived.
4 1/20 No symptoms.*
5 1/20 No symptoms.*
6 1/10 Tetanus. Killed on 6th day.
7 1/10 Tetanus. Killed on 7th day.
8 1/2 No symptoms.*
9 1 Tetanus. Killed on 11th day.
Controls 6 5 died of tetanus within 48 hours.
1 showed no symptoms during 4
weeks' observation.
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TABLE 3
MICE
Immunization: subcutaneous injection of 0.1 cc. of alum-precipitated toxoid, fol-
lowed in 2 weeks by 0.1 cc. of plain toxoid. Eight weeks later blood was taken, and
each of the immune mice and controls received 100,000 spores and 5 mg. of CaCl2
in a 0.4 cc. volume.
Number of mice
Immunized
2
Controls 5
Units of antitoxin
per cc. of serum
<1/10
1/10 or more
Results
I died (60 hours). None of the
others showed symptoms.
All died of tetanus in 48-96 hours.
TABLE 4
MICE
Immunization: at the same time and with the same quantities as the mice of the
preceding experiment. Twenty-two weeks later blood was taken and the immune
mice and the controls each received 5000 spores and 5 mg. of CaCl2 in a 0.1 cc.
volume.
Number of mice
Im2
Immunized 2
(4
Units of antitoxin
per cc. ofseruim
<1/20
1/20
>1/20
Controls 8
Results
Both died (72 and 96 hours).
Both died (120 hours).
1 moribund-killed on 7th day. 2
paralyzed but survived. I showved
no symptoms.
All dead or dying in 48 hours.
A study of the above tables suggests that it is probably imprac-
tical to define the minimum titer which will assuredly protect
against tetanus. The deciding factor would seem to be the amount
of toxin produced in an infection, and to predict this is impossible.
It is believed that the infections recorded can be considered as over-
whelming, although an occasional control survived. It is possible
also, of course, that in some of the immune animals which showed
no symptoms the infection did not establish itself.
Jones and Jamieson5 have reported the results of some simi-
lar experiments on guinea-pigs in which complete protection was
obtained. However, the lowest serum titer of antitoxin in their
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animals was 4 units per cubic centimeter and the infection itself
failed to kill the controls until the fourth or fifth day, so that
conditions were favorable for survival. With these facts in mind,
it seems probable that their estimation of 2 to 3 units of antitoxin
per cubic centimeter of blood as the amount required may be some-
what high. Such titers may guarantee immunity but they are far
too great to be attained practically in man, and the results reported
in the preceding protocols imply that, in the main, lower titers
are acceptable.
Another point suggested in the above experiments is that the
number of spores injected is apparently relatively unimportant
and that it is the concentration of the necrotizing agent which deter-
mines the speed and severity of the infection.
The Speed of the Secondary Response in Immune Individuals
Twenty-one medical students volunteered to receive the immu-
nizing treatment. Two subcutaneous injections, each of one cubic
centimeter, of alum-precipitated tetanus toxoid were given eleven
weeks apart, and blood samples were taken seven weeks later.
The antitoxin titers at this time are summarized below. No pre-
liminary titration of the bloods was made, as it has been generally
found that in the great majority of cases "normal" man-does not
have a measurable amount of tetanus antitoxin.
TABLE 5
Unitsofantitoxin
Numberofstudents percc. ofserum
1 2
1 1
5 1/2
3 1/5
7 1/10
3 1/20
1 1/40
Thirty-two weeks after this titration thirteen of the group
received, unless otherwise noted, a "recall" injection of 0.5 cc.
of the alum-precipitated toxoid. Blood samples were taken imme-
diately prior to injection and at intervals thereafter, and the anti-
toxin was titrated.
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TABLE 6
MEASUREMENT OF ANTITOXIN RESPONSE IN IMMUNE INDIVIDUALS
(IN UNITS PER CUBIC CENTIMETER OF SERUM)
Original titer
0 2 3 4 5 7
R.N.B. 2 1/51 - 1/5 1/2 2 -
R.W.B. 1/5 1/50 1/50 < 1/20 1/20 1/2 -
P.C. 1/51 1/5 1/5 1/3 1/2 5
W.K. 1/2 1/50 1/50 1/20 1/10 - _
S.K. 1/2 1/202 1/20 - -
B.L. 1/2 < 1/50 < 1/50 1/50 1/20 1/10 1/2 -
R.M. 1/20 1/50 1/50
C.P. 1/10 1/50 1/50 1/10 1/2
A.S. 1/10 < 1/50 1/50 1/20
W.S. - 1/50 1/2 -
W.W. 1/2 1/20 1/20 1/20 1/5 -
L.G.W. 1/20 <1/50 - 1/20 1
L.J.W. 1/10 1/50 1/20 1
'0.05 cc. of plain toxoid intracutaneously.
2 2 mouse minimum lethal doses of plain toxoid intracutaneously.
8 10 15 40 140
20-
10- 5 2
- 1/20-
- I
1/2-
-- 1-
/2- -
/5 -
Attention may be called to two points illustrated in the above
tables. In the first place, the response to the same treatment of a
homogeneous group is rather varied, as is the maintenance of the
level of antitoxin. These facts have, of course, been abundandy
demonstrated in many immunizing processes, but it is perhaps of
advantage to emphasize them in this connection, since the response
of some individuals to the routine two injections of tetanus toxoid
may not result in an immunity of magnitude sufficient for what
is deemed to be adequate protection. Secondly, the response to a
subsequent injection is not significant until the fourth or fifth day.
Discussion
Assuming that tetanus immunity in man and in animals can
be compared, a consideration of the antitoxin titers found in the
former after the administration of 1500 units prophylactically,
and in the latter at the time of infection makes it possible to draw
a tentative conclusion as to the amount of circulating antitoxin which
can give a fairly certain protection. In both cases values of about
1/10 unit are obtained. This quantity is, on the one hand, not
sufficiently great to protect all animals against a maximum infec-
tion, and, on the other, is probably much larger than is necessary
to care for many infections resulting from wounds judged to be
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too slight for surgical attention. It is probably large enough also
to care for the majority of injuries which receive surgical treat-
ment. It would seem, however, pending the acquisition of more
information, that conservative opinion might demand the mainte-
nance of such a titer in cases where much reliance is to be placed on
the immunity, that is, where antitoxin prophylaxis is to be with-
held or surgical attention is not available.
As to the efficacy of injections of toxoid at the time of injury
in subjects actively immune but of low titer, no definite statement
can yet be made. If the titer is 1/50 unit or less such injection
results in an increase to 1/5 unit in from five to eight days. Whether
or not this is soon enough we do not know. The incubation period
of tetanus, except in fulminating cases, is stated to be, on the aver-
age, from seven to ten days. It is probable that toxin has been
elaborated and fixed to the nerve tissue some time prior to the
manifestation of symptoms, and as antitoxin is generally held to
be of questionable value in neutralizing such bound toxin, the
influence of such a delayed rise in titer cannot be determined with-
out further study. At any rate, such injection should certainly be
made if antitomin is to be Withheld.
On the other hand, there can be no doubt of the value of an
immunity which is of even slight degree as measured by the titer
of circulating antitoxin. In the experiments described above many
of the animals possessing low titers showed either local tetanus or
delayed symptoms of a sort which, in man, might well be treated
with the usual non-specific methods. Then, too, the course of the
tetanus in the immune animals suggests that in most cases the
bulk of the toxin was neutralized, and only a small amount, per-
haps as little as one minimum lethal dose, escaped. The guinea-
pigs of Table 2, for instance, which showed symptoms did not do
so until the third or fourth day, when all of the controls were
dead, and the extension of the paralysis in them was slow. Some
tentative experiments in which as many as sixteen units of heter-
ologous antitoxin were injected intraperitoneally into guinea-pigs
prior to infection have given results suggesting the possibility that
an actively immune animal, even with a low titer, has a generalized
immunity which the passively protected animal lacks.
Summary
1. A consideration of the antitoxin titers found in man after
the prophylactic injection of 1500 units and in immunized guinea-
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pigs and mice at the time of infection suggests that 1/10 or 1/5
unit per cubic centimeter of serum can give a fairly certain protection.
2. Injection of toxoid into actively immune subjects results
in a significant increase in antitoxin on the fourth or fifth day.
Addendum. The following note, while it does not bear closely on the
subject matter of this paper, is of some interest.
TIhe literature contains references to repeated tetanus infections in man,
as well as to the lack of antitoxin in subjects who have recovered from
tetanus. This suggests that in man tetanus toxin is a relatively poor antigen,
or, rather, that the antigenic dose is large compared to the toxic dose. During
the progress of this investigation an opportunity was given to study the
response of a man who had suffered from an attack of tetanus some eight
years previously. The attack was not a severe one, apparently, for symptoms
had been manifest for several days prior to the administration of antitoxin.
It might reasonably be expected, therefore, that in the time of its unhampered
action the toxin might have stimulated some degree of sensitization which
could be made manifest following an injection of toxoid. Accordingly, after a
preliminary blood sample had been collected, an injection of 0.5 cc. of alum-
precipitated tetanus toxoid was made, and nine days later another blood
sample was taken. Half cubic centimeter amounts of each of the sera failed
to sbow any detectable neutralization of two mouse minimum lethal doses of
tetanus toxin. It would seem that the toxin concerned in the attack of
tetanus had not, in this case, constituted an antigenic stimulus.
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